Bladder cancer Board decisions

The Veteran's claims for earlier effective dates for service connection have been denied.,The Veteran’s TDIU claim has also been remanded.

The Board denied the Veteran's claim for service connection for bladder cancer, finding that there was no evidence linking his current condition to his military service.

The Board denied the Veteran's claim for service connection for bladder cancer due to a lack of evidence showing at least 30 days of service at Camp Lejeune, and thus unable to establish presumptive exposure. The Veteran's statements regarding his service were found not credible.

The Veteran's bladder cancer is granted service connection due to exposure to herbicide agents. Service connection for hypertension is dismissed as the Veteran withdrew his appeal during a hearing.

The Board has decided to remand the claims for service connection for prostate and bladder cancer, as well as colon and stomach cancers with metastasis. The VA will need to obtain additional service records and TDY orders to determine if the Veteran was exposed to herbicides during his service.

The Veteran's prostate cancer was not shown in service or for many years thereafter, and is not otherwise etiologically related to active duty service.,There is no evidence of bladder cancer prior to the Veteran's death.

The Veteran's appeal for service connection of bladder cancer was dismissed due to his death prior to a final decision.

The Veteran's bladder cancer is not subject to presumptive service connection due to herbicide exposure. The Board finds that remand is warranted for a new medical opinion regarding the etiology of his bladder cancer, including whether it is related to in-service conditions or exposure.

The Veteran's service-connected Peyronie’s disease and bladder cancer have been found to prevent him from securing or following substantially gainful employment. The case is remanded for a new VA examination to assess the current severity of his Peyronie’s disease.

The Board denied service connection for bladder cancer claimed as secondary to ionizing radiation exposure during military service, finding no reasonable possibility that the condition was caused by such exposure and noting that there is no evidence of a present disability within one year of discharge.

The Veteran's bladder cancer is presumed to have been incurred in service due to his exposure to herbicide agents, including Agent Orange.

The Board has remanded the case due to new evidence showing that the prostate cancer is related to bladder cancer, which was already service-connected. The claim will be reconsidered by the originating agency.

The Veteran's bladder cancer is granted service connection due to presumed exposure to herbicide agents in Vietnam. However, his kidney cancer is denied as there is no evidence of a direct relationship with service or presumed herbicide exposure.

The Veteran's bladder cancer is presumed to be related to his service in the Republic of Vietnam, and he has been granted service connection for this condition.

The Board has granted service connection for bladder cancer, finding that the Veteran's exposure to herbicide agents in Vietnam during his active duty service is presumed and thus entitles him to this benefit.

The Veteran's bladder cancer is presumed to have been caused by his herbicide exposure during service, and the claim for service connection is granted.

The Veteran's bladder cancer and its residuals are granted as service-connected due to exposure to herbicide agents in Vietnam.

The Veteran's bladder cancer is presumed to have been incurred as a result of his in-service exposure to Agent Orange. As such, the claim for service connection has been granted.

The Veteran's bladder cancer is presumed to have been caused by exposure to herbicides during service, and the claim for service connection is granted.

The Veteran's bladder cancer is granted as due to presumed exposure to herbicide agents. The initial rating for coronary heart disease remains at 10 percent from July 9, 2013 to November 18, 2016 and at 30 percent thereafter.